WO1997017438A1 - Procede de clonage par expression d'un gene codant une proteine liee a un ligand - Google Patents
Procede de clonage par expression d'un gene codant une proteine liee a un ligand Download PDFInfo
- Publication number
- WO1997017438A1 WO1997017438A1 PCT/JP1996/003233 JP9603233W WO9717438A1 WO 1997017438 A1 WO1997017438 A1 WO 1997017438A1 JP 9603233 W JP9603233 W JP 9603233W WO 9717438 A1 WO9717438 A1 WO 9717438A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- membrane
- protein
- ligand
- dna
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
Definitions
- the present invention relates to a method for expression cloning of a gene encoding a ligand binding protein. According to the present invention, a gene encoding a ligand-binding protein having useful biological activity can be efficiently cloned.
- a ligand is a molecule that specifically binds to a protein, and a protein that binds to a ligand is called a ligand-binding protein.
- the ligands include various drugs, nucleotides, metal ions, and the like.
- the ligand-binding proteins include proteins or enzymes that are usually called receptors (Recebu Yuichi), and others. There are various bioactive proteins. Ligand is thought to be involved in signal transduction of various physiological activities by binding to the ligand-binding protein.
- metal ions are known to play an important role in living organisms.
- zinc ions have been shown to bind to a number of transcriptional regulators and to exert their functions.
- transcription factors are involved in development, differentiation, inflammation, cell proliferation, etc. Is known to be involved in
- transcriptional regulators are present only in minute amounts in living organisms, and their purification and molecular structure analysis have been difficult.
- Attar RM et al. (Mol. Cell. Biol. (1992) 12, 2432-2443) use a DNA probe of a serum response factor to code for a protein having a zincfinger structure that binds to a serum response factor. It has been reported that the cloned gene has been cloned.
- the present inventors have conducted intensive studies on a method for cloning a gene that efficiently encodes a ligand-binding protein. As a result, the present inventors have used DNA libraries containing various genes, expressed them, and expressed the ligands. The present inventors have found that a ligand-binding protein can be efficiently and easily obtained by directly identifying a ligand-binding protein by utilizing its binding property to a gland-binding protein, and completed the present invention. .
- an object of the present invention is to provide a novel method for cloning a gene encoding a ligand-binding protein with high efficiency, which has not been achieved by the conventional method. More specifically, the present invention provides a novel method for efficiently and easily cloning a gene encoding a zinc ion binding protein.
- the present invention provides a protein produced by culturing a host into which a DNA inserted into an expression vector has been introduced, expressing the DNA, and bringing a membrane into contact with the plate. Is transferred from the plate to the membrane, the membrane is removed from the plate, and a labeled ligand is added to the membrane to bind the ligand to the protein.
- a gene encoding a ligand-binding protein which comprises detecting a label bound to the protein and isolating DNA from a host clone on a plate corresponding to a positive site on the membrane.
- a DNA library obtained by inserting DNA into an expression vector is prepared.
- the source of the DNA can be any cell or tissue that clones the DNA encoding the desired ligand binding protein, such as brain, thyroid, lung, heart, thymus And tissues such as spleen, spleen, kidney, adrenal gland, intestine, skeletal muscle, bone marrow, epithelium, umbilical cord, blood vessel, blood, and cells derived therefrom.
- cDNA or dienomic DNA may be used, but cDNA is preferable.
- cDNA mRNA can be purified from the target cell or tissue, and cDNA can be synthesized using reverse transcriptase and used.
- the above-mentioned cells and tissues may be normal, or may be in a corresponding pathological state when targeting a ligand-binding protein associated with a specific disease.
- artificially created pathological conditions that is, cells and tissues derived from various disease state models can be used.
- these cells and tissues may be derived from fetuses or adults, humans or non-human animals.
- Preparation of the DNA library can be performed according to a known standard method.
- an expression vector for constructing a DNA library any vector commonly used for the preparation of a DNA library can be used, for example, a phage vector, a plasmid vector, etc. Is used. These include expression control sequences such as commonly known promoters and enhancers, and are capable of expressing the DNA contained therein, and further preferably include expression induction sequences. Examples of phage vectors include ⁇ ⁇ ⁇ and ⁇ gt 11.
- any vector which is commonly used in the DNA library and which has the infectivity of the vector can be used.
- those capable of controlling the expression induction are preferred.
- those capable of controlling the expression induction are preferred.
- the expression vector those which are introduced and express the DNA in the presence of an expression inducing agent are preferable, and as the expression inducing sequence, the 1 ac operon and the 1 ac promoter are used overnight.
- Isopropyl-D-thiogalactoside (IPTG) is used as a corresponding expression inducer.
- the host cells transformed with the expression vector into which the DNA constituting the DNA library has been inserted are inoculated on a solid plate medium and cultured.
- the culturing may be performed under generally known conditions such that the DNA library is favorably expressed in the host cell.
- a phage vector is used as an expression vector
- a plaque is formed.
- a protein is produced in the black portion by the expression of the inserted DNA, and the protein is produced by bringing a membrane into contact with the plate. To the membrane. If the expression vector requires an expression inducer for the expression of DNA, add the expression inducer.
- the expression inducer may be added directly to the culture solution in advance, or the membrane may be impregnated with the expression inducer. After adding the expression inducer to the membrane, the membrane is brought into contact with the surface of the plate. As a result, the expression inducing agent is transferred from the membrane to the plate medium, and the production of the protein coded by the DNA is induced, and the protein is transferred to the membrane.
- a membrane impregnated with an expression inducer and capable of transferring proteins is preferable, and a commonly used plotting membrane, for example, a nitrocellulose membrane or a nylon membrane A lon film is used.
- the membrane may be washed to remove medium components, cells, and the like transferred from the plate, and further treated with a protein denaturant.
- a protein denaturing agent care dizine hydrochloride, urea or various reducing agents can be used. Denaturation of the protein is performed by treating the membrane with a buffer containing the above-mentioned denaturant, for example, a Tris-HCl buffer.
- This denaturation is performed so that the undesired higher-order structure of the protein formed in the bacterial cells is once destroyed, so that the target protein can easily bind to the ligand.
- the protein denaturant is washed away by washing the membrane with a washing solution, for example, a Tris-HCl buffer.
- a washing solution for example, a Tris-HCl buffer.
- the protein on the membrane is regenerated by treating the membrane with the regenerating solution.
- a solution containing the labeled ligand is applied to the membrane.
- Any ligand may be used as long as it binds to a protein, and includes various drugs, nucleotides, metal ions, and the like. More and rather are preferred, Li cancer de is zinc ions, isotopes with radioactive (6 5 Z n) is then rather illustrative preferred.
- the labeled ligand binds to the corresponding protein on the membrane, and By detecting the label, the position of the positive clone on the plate can be determined.
- the label and its detection means any of those used in various biological assays can be used.
- the ligand is a metal ion
- the radioisotope of the metal ion is labeled. It can be used as a recognized ligand.
- a fluorescent label, a biotin label, an enzyme label, and an antibody label can be used depending on the properties of the ligand.
- the detection means use any conventional means depending on the labeling substance. For example, when using a radioisotope of metal ion as a labeled ligand, positive spots are identified by autoradiography or a bio-image analyzer, and the The host clone on the plate at the corresponding position can be identified. Further, as another label detecting means, there is an image analysis device or the like corresponding to the above-mentioned labeling substance.
- the host clone thus obtained can be purified by repeating the subsequent steps from the plate culture. If a positive clone is identified in this way, the vector can be isolated from the cells of the host clone by a conventional method, and then the desired DNA can be cut out.
- DNA encoding a ligand-binding protein can be very efficiently cloned from normal and diseased cells and tissues of any species, and these can be used as target molecules. It will be possible to screen new drugs.
- Uni-ZAPXR library (Stratagene) was used. E. coli (XL 1 one B 1 ue, Stratagene Co.) were infected with, plated mixed with bets Tsupuagarosu to 1 2 cm square plates at a rate of about 1 x 1 0 4 pfu. Plates were incubated at 42 ° C for approximately 3-4 hours. Some plaque After growing, place a plate of nitrocellulose impregnated with 20 mM isopropyl-D-thiogalactone (IPTG) on the plate for approximately 4 hours at 37 ° C. After incubation, the proteins were expressed and transferred to the membrane.
- IPTG isopropyl-D-thiogalactone
- the protein on the membrane was denatured with solution A (6 M guanidine HC1, 30 mM Tris-HC1 (pH 7.4), 5 mM dithiothreitol (DTT)). After rinsing with solution B (30 mM Tris-HC1 (pH 7.4), 150 mM NaC1) to remove guanidine, solution C (30 mM Tris-HC1 (pH 7.4) The protein on the membrane was regenerated with 7.4), 150 mM NaCl, 2 mM DTT). The membrane was rinsed again with solution D (10 mM Tris-HC1 (pH 7.4), 150 mM NaCl) and solution E (10 mM Tris-HCl (pH 7.
- the insert contains a part of the PLZF (promyelocytic 1 eukaemiazincfinger) gene that encodes kruppel-1 ikezinc: finger protein.
- PLZF is a zinc ion-binding transcriptional regulator with several zinc finger motifs on the C-terminal side. It is a nodal factor.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU73401/96A AU703145B2 (en) | 1995-11-07 | 1996-11-05 | Method for expression cloning of gene encoding ligand-bound protein |
EP96935545A EP0867505A4 (en) | 1995-11-07 | 1996-11-05 | METHOD FOR THE EXPRESSION CLONING OF A GENE ENCODING A LIGAND-BOUND PROTEIN |
US09/068,461 US6846624B1 (en) | 1995-11-07 | 1996-11-05 | Expression cloning process for gene coding for a zinc-binding protein |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7/288784 | 1995-11-07 | ||
JP28878495 | 1995-11-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997017438A1 true WO1997017438A1 (fr) | 1997-05-15 |
Family
ID=17734685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/003233 WO1997017438A1 (fr) | 1995-11-07 | 1996-11-05 | Procede de clonage par expression d'un gene codant une proteine liee a un ligand |
Country Status (4)
Country | Link |
---|---|
US (1) | US6846624B1 (ja) |
EP (1) | EP0867505A4 (ja) |
AU (1) | AU703145B2 (ja) |
WO (1) | WO1997017438A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003292599A1 (en) | 2002-12-20 | 2004-07-14 | Shigeki Higashiyama | Method of screening cell growth inhibitor and cell growth inhibitor |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206152A (en) | 1988-04-08 | 1993-04-27 | Arch Development Corporation | Cloning and expression of early growth regulatory protein genes |
CA2081213A1 (en) * | 1990-05-08 | 1991-11-09 | Richard A. Lerner | Metal binding proteins |
US5759803A (en) * | 1992-05-13 | 1998-06-02 | Dana-Farber Cancer Institute | Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA |
JPH06296489A (ja) * | 1992-11-20 | 1994-10-25 | Univ Texas Syst | 網膜芽腫−関連タンパク質をコードする細胞性遺伝子 |
US5679548A (en) * | 1993-02-02 | 1997-10-21 | The Scripps Research Institute | Methods for producing polypeptide metal binding sites and compositions thereof |
NZ261571A (en) * | 1993-02-04 | 1997-03-24 | Denzyme Aps | Producing correctly folded proteins using multiple denaturation and renaturation cycles |
US5891418A (en) * | 1995-06-07 | 1999-04-06 | Rhomed Incorporated | Peptide-metal ion pharmaceutical constructs and applications |
-
1996
- 1996-11-05 US US09/068,461 patent/US6846624B1/en not_active Expired - Fee Related
- 1996-11-05 AU AU73401/96A patent/AU703145B2/en not_active Ceased
- 1996-11-05 WO PCT/JP1996/003233 patent/WO1997017438A1/ja not_active Application Discontinuation
- 1996-11-05 EP EP96935545A patent/EP0867505A4/en not_active Withdrawn
Non-Patent Citations (3)
Title |
---|
J. IMMUNOL., Vol. 155, No. 9, 01 November 1995, S. NAGULAPALLI et al., "Multiple Proteins Physically Interact with PU. 1". * |
MOL. CELL. BIOL., Vol. 12, No. 5, May 1992, R.M. ATTAR et al., "Expression Cloning of a Novel Zinc Finger Protein That Binds to the c-fos Serum Response Element". * |
See also references of EP0867505A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP0867505A1 (en) | 1998-09-30 |
AU703145B2 (en) | 1999-03-18 |
US6846624B1 (en) | 2005-01-25 |
EP0867505A4 (en) | 2000-01-19 |
AU7340196A (en) | 1997-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kataoka et al. | Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor | |
Galéra et al. | c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. | |
Chang et al. | Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2 | |
Taubman et al. | Cloning and characterization of mammalian myosin regulatory light chain (RLC) cDNA: the RLC gene is expressed in smooth, sarcomeric, and nonmuscle tissues. | |
Neuteboom et al. | Pbx raises the DNA binding specificity but not the selectivity of antennapedia Hox proteins | |
Muckenthaler et al. | Iron‐regulatory protein‐1 (IRP‐1) is highly conserved in two invertebrate species: Characterization of IRP‐1 homologues in Drosophila melanogaster and Caenorhabditis elegans | |
JPH111498A (ja) | Myc結合性亜鉛フィンガータンパク質、その製造方法及びその使用 | |
US5302698A (en) | DNA coding for protein binds to enhancer of α-fetoprotein gene | |
AU2003215094A1 (en) | Zinc finger libraries | |
US6368794B1 (en) | Detection of altered expression of genes regulating cell proliferation | |
WO1997017438A1 (fr) | Procede de clonage par expression d'un gene codant une proteine liee a un ligand | |
NOZAKI et al. | Molecular cloning of Elk-3, a new member of the Ets family expressed during mouse embryogenesis and analysis of its transcriptional repression activity | |
JP2000509272A (ja) | 新規タンパク質―traf6 | |
JPH09187298A (ja) | リガンド結合蛋白質をコードする遺伝子の発現クローニング方法 | |
AU714793B2 (en) | Novel stress proteins | |
Pan et al. | Drosophila engrailed‐1, 10‐phenanthroline chimeras as probes of homeodomain‐DNA complexes | |
WO2001038531A1 (fr) | Nucleoproteine humaine possedant un domaine www et polynucleotide codant cette nucleoproteine | |
JPH07508655A (ja) | セロトニン作動性レセプター(5ht6)活性を有するポリペプチド,これらのポリペプチドをコードする核酸,およびそれらの利用 | |
JPH07145197A (ja) | Ets転写因子 | |
JPH11299489A (ja) | 中性アミノ酸トランスポーター及びその遺伝子 | |
WO2001032869A1 (fr) | PROTEINES HUMAINES SE LIANT A LA TYROSINE KINASE HUMAINE Hck ET GENES CODANT POUR CES PROTEINES | |
JPH1084971A (ja) | 新規ストレス蛋白質 | |
Sargent | THE RAT SERUM ALBUMIN GENE. | |
JPH09252777A (ja) | マウス肝癌細胞由来増殖因子 | |
JPH1146766A (ja) | ヒト核蛋白質とこの蛋白質をコードするヒト遺伝子 およびcDNA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09068461 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996935545 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1996935545 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996935545 Country of ref document: EP |